GSK plans to assess rheumatoid arthritis drug otilimab for Covid-19
GSK identified the drug after screening its portfolio and pipeline for potential against Covid-19. Credit: Montgomery County Planning Commission.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more